FDA Oncology Announcements

Non-taxane microtubule dynamics inhibitor × Clear all

3 Announcements

Eribulin

Drug: HALAVEN (eribulin) · Non-taxane microtubule dynamics inhibitor
Condition: Sarcoma

Eribulin Mesylate

Drug: Halaven (eribulin mesylate) · Non-taxane microtubule dynamics inhibitor
Condition: Breast

Ixabepilone

Drugs: Ixempra (ixabepilone) · Non-taxane microtubule dynamics inhibitor, Ixempra (injection)
Condition: Breast